Multivariate logistic regression of significant variables. by Daniella Justesen (22170253)

Subjects:

Henoch-Schönlein purpura nephritis associated with monoclonal gammopathy of renal significance: a case report by Hui Zhao (7395)

“…The Henoch-Schönlein purpura nephritis (HSPN) that cannot be relieved by treatment with glucocorticoid and immunosuppressive agents suggests the presence of monoclonal gammopathy in adult patients. The present study reports on a single case of HSPN associated with IgA-κMGRS. …”

Study characteristics of case reports and case series studies. by Sujit Kumar Sah (13170345)

Subjects:

Data Sheet 1_Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.docx by Hongying Liu (773217)

“…However, certain genetic profiles, such as BRCA1/2 mutations, high tumor mutational burden (TMB), or microsatellite instability-high (MSI-H), may enhance sensitivity to these therapies. This report presents two cases of advanced pancreatic cancer with BRCA1/2 mutations treated with a combination of chemotherapy and immune checkpoint inhibitors. …”

Proportion of the increase (green) or decrease (red) in forest cover in areas with different fire recurrences in Africa, according to the Mann-Kendall test and statistically significance values. by Oswaldo Maillard (20660661)

Multivariate logistic regression of significant variables stratified by age. by Daniella Justesen (22170253)

Subjects:

Reported cases of scrub typhus. by Jia-Wei Tian (10647704)

Quality Assessment of Case Reports and Case Series. by Sujitha Selvarajah (11432769)

Subjects:

Number of publications reporting human ehrlichiosis cases and number of reported cases by country 1987–2023. by Larissa Gygax (19321697)

Subjects:

Data Sheet 1_Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms.pdf by Xiaohui Huang (458909)

“…Currently, no standardized therapeutic protocol exists for DSP-MG due to its scarcity and clinical heterogeneity. Herein, we report a case of a 68-year-old female patient with DSP-MG who showed significant clinical improvement during an acute exacerbation after treatment with the FcRn antagonist efgartigimod, following the failure of conventional therapy. …”

Histopathology findings in reported cases of mycetoma. by Mohammad Zeeshan (141644)

Subjects:

Reported and predicted weekly confirmed cases. by Hiroki Koshimichi (19369838)

Reported human ehrlichiosis cases by country. by Larissa Gygax (19321697)

Subjects:

Image_1_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Image_4_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Table_1_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.docx by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Image_3_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Image_2_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Significance test results of the optimized model. by Ying Wang (11406)

Results of false positive report probability analysis for significant findings. by Md. Harun-Or-Roshid (10270803)